Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB vs PANCRELIPASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALBOCICLIB vs PANCRELIPASE: Safety Overview

Metric PALBOCICLIB PANCRELIPASE
Total FAERS Reports 91,024 724
Deaths Reported 11,066 66
Death Rate 12.2% 9.1%
Hospitalizations 13,442 281
Average Patient Age 66.0 yrs 52.0 yrs
% Female Patients 97.7% 50.4%
FDA Approval Date Feb 3, 2015 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription Discontinued